Main > > >AORTA/AORTIC. *

Ascending Aortic Prosthesis. (AAP)
EU>CE Mark Date: 2020. 02.27.
(*) Company : CryoLife.
TradeMark: On-X AAP
Web-Site :
www.cryolife.com/products/on-x-
heart-valves/ascending-aortic-
prosthesis/
UpDate: 2020. 03.01.




Cardio.>Cerebral Embolic Protection Device.
Use in Transcatheter Heart Procedures.
- protect the brain during TAVI & TAVR
procedures
- debris such as calcium or tissue can
break loose during the procedure,
travel through the bloodstream towards
the brain and potentially cause
neurological and neurocognitive damage
- protect patients against the risk of
stroke
EU Approval Date: 2020. 03.10.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 03.15.




Cardio.>Cerebral Embolic Protection System.
- protect the brain during TAVI & TAVR
procedures
- debris such as calcium or tissue can
break loose during the procedure,
travel through the bloodstream towards
the brain and potentially cause
neurological and neurocognitive damage
- protect patients against the risk of
stroke
EU Approval Year : 2014.
USA Approval Year: 2017.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 08.18.




Cardio.>Temporary Pacing Guidewire During Transcatheter Aortic Valve Replacement (TAVR) & Balloon Aortic Valvuloplasty (BAV) Procedures.
USA Clearance Date: 2020. 01.22.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 02.06.



Cardio.>Thoracic Stent Graft System.
Indications: Descending Thoracic Aorta
(DTA) Lesions>
>Blunt Thoracic Aortic Injuries (BTAIs)
>IntraMural Hematomas (IMHs)
>Penetrating Atherosclerotic Ulcers
(PAUs)
>Thoracic Aortic Aneurysms (TAAs)
>Type B Aortic Dissections (TBADs)
Minimally Invasive Repair.
EU Approval Date : 2018. 11.13.
JP Approval Date : 2019. 10.31.
USA Approval Date: 2018. 10.23.
(*) Company; TradeMark & Web-Site Avai-
lable on Request.
UpDate: 2019. 11.03.




Cardio.>Valves>Repair>Aortic>BiCuspid Annuloplasty Device.
USA Approval Date: 2017. 08.15.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 02.24.




Cardio.>Valves>Replacement>Aortic>Sutu-reLess Valve.
EU Approval Year : 2011.
JP Approval Date : 2018. 06.11.
USA Approval Year: 2016.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 02.21.




Vascular Surgery>Abdominal Aortic Aneu- rysm (AAA). Treat.: Stent Graft System in Patients with Neck Lengths down to 4mm and <=60° Infra-Renal Angulation when used in combination with the "TradeMark B" System.
The Expanded Indication enables the "TradeMark A" stent graft to be used in conjunction with the "TradeMark B" system to treat a wider range of patients with short, hostile aortic neck anatomies, independent of renal stenting.
Until now, some patients with short infra-renal necks (<10mm) were considered ineligible for endovascular aneurysm repair (EVAR), leaving them with limited treatment options. Up to 30 to 40 percent of patients with AAA disease are considered unsuitable candidates for conventional EVAR.1.
According to estimates from physicians across Europe and the United States, more than one-third of these patients have AAA proximal neck anatomies <= 10mm.2.
"Due to the complex and hostile proximal aortic neck anatomy, this patient population remains a challenge to treat,"
"With minimal time added to the procedure, "TradeMark B" fixation has been proven to enhance outcomes and durability, establishing a new treatment approach that addresses this critical patient need."
EU Approval : 2016. 12.
USA FDA Approval: 2017. 10.09.
(*) Company; Patents; TradeMarks &
Web-Sites Available on Request.
UpDate: 2019. 08.10.




>AORTA/AORTIC. *'s products
This section has no products